TMCnet News
World Mycoplasma Diagnostics Market 2017-2021 - Emerging Opportunities and Growth Strategies - Research and MarketsThe "2017-2021 World Mycoplasma Diagnostics Market: Emerging Opportunities and Growth Strategies" report has been added to Research and Markets' offering. The report presents a detailed analysis of the Mycoplasma diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Mycoplasma definition, epidemiology and etiology are reviewed. For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Mycoplasma tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. The report provides the 5-year test volume and sales forecasts by country for the following market segments:
Key Topics Covered: I. Introduction II. Worldwide Test Overview, Technologies and Instrumentation A. Background, Diagnostic Tests, Vaccines and Drugs B. Instrumentation Review Operating Characteristics, Features and Selling Princes of Leading Infectious Disease Automated and Semi-automated Analyzers C. Emerging Infectious Disease Diagnostic Technologies 1. Molecular Diagnostics 2. Monoclonal Antibodies 3. Immunoassays 4. Differential Light Scattering 5. Information Technology 6. Artificial Intelligence 7. Liposomes 8. Flow Cytometry 9. Chromatography 10. Diagnostic Imaging 11. Gel Microdroplets 12. Others D. Personal Testing III. Country Analyses: Sales and Volume Forecasts IV. Major Product Development Opportunities A. Instrumentation B. Reagent Kits and Test Systems/Panels C. Information Technology D. Auxiliary Products V. Design Criteria for Decentralized Testing Products VI. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies for Decentralized Testing Markets VII. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges VIII. Competitive Assessments
For more information about this report visit https://www.researchandmarkets.com/research/m6pd55/20172021_world
View source version on businesswire.com: http://www.businesswire.com/news/home/20171013005415/en/ |